Evidence map›Paper›PMID 32521358›Full record

ArticleJournal of psychosomatic research2020

Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients.

Brett D Thombs, Linda Kwakkenbos, Marie-Eve Carrier, Angelica Bourgeault, Lydia Tao, Sami Harb, Maria Gagarine, Danielle Rice, Laura Bustamante, Kelsey Ellis and 21 more

Open access · hybridAbstract readClinical Trial Protocol
In one paragraph

Article in Journal of psychosomatic research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 20 institutions in 6 countries.

Brett D ThombsLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Department of Psychology, McGill University, Montreal, Quebec, Canada; Department of Educational and Counselling Psychology, McGill University, Montreal, Quebec, Canada; Biomedical Ethics Unit, McGill University, Montreal, Quebec, Canada. Electronic address: brett.thombs@mcgill.ca.
Linda KwakkenbosDepartment of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, the Netherlands.
Marie-Eve CarrierLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Angelica BourgeaultLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Lydia TaoLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Sami HarbLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Maria GagarineLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
Danielle RiceLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychology, McGill University, Montreal, Quebec, Canada.
Laura BustamanteDepartment of Applied Human Sciences, Concordia University, Montreal, Quebec, Canada.
Kelsey EllisFaculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada.
Delaney DuchekFaculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada.
Yin WuLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Parash Mani BhandariLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
Dipika NeupaneLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
Andrea Carboni-JiménezLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Richard S HenryLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Ankur KrishnanLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Ying SunLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Brooke LevisLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Centre for Prognosis Research, School of Primary, Community and Social Care, Keele University, Staffordshire, UK.
Chen HeLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Kimberly A TurnerLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Andrea BenedettiDepartment of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, Quebec, Canada.
Nicole Culos-ReedDepartment of Applied Human Sciences, Concordia University, Montreal, Quebec, Canada; Department of Oncology, Cumming School of Medicine, Calgary, Canada; Department of Psychosocial Resources, Tom Baker Cancer Centre, Alberta Health Services, Calgary, Alberta, Canada.
Ghassan El-BaalbakiDepartment of Psychology, Université du Québec à Montréal, Montreal, Quebec, Canada.
Shannon HebblethwaiteDepartment of Applied Human Sciences, Concordia University, Montreal, Quebec, Canada.
Susan J BartlettDepartment of Medicine, McGill University, Montreal, Quebec, Canada; Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
Laura DyasScleroderma Foundation Michigan Chapter, Southfield, MI, USA.
Scott PattenDepartment of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
John VargaNorthwestern Scleroderma Program, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 Patient Advisory Team
SPIN Investigators
Jewish General Hospital · CAUniversité de Sherbrooke · CAHôpital Claude Huriez · FRThe University of Melbourne · AUDalhousie University · CADélégation Paris 5 · FRNorthwestern University · USUniversity of Calgary · CACentre Hospitalier Universitaire de Rouen · FRHospital for Special Surgery · USMcGill University Health Centre · CAScleroderma Foundation · USHôpitaux Universitaires de Strasbourg · FRMcGill University · CARadboud University Nijmegen · NLSorbonne Université · FRUniversité du Québec à Montréal · CAUniversity of Ottawa · CAAix-Marseille Université · FRCentre Hospitalier de l’Université de Montréal · CA

Funding

Institutional Career Development CoreKL2TR003168 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILLER, CHARLES C · 2019 to 2023
$4.9M
NCATS NIH HHS KL2 TR003168
6 · The paper itself

Abstract

objectiveContagious disease outbreaks and related restrictions can lead to negative psychological outcomes, particularly in vulnerable populations at risk due to pre-existing medical conditions. No randomised controlled trials (RCTs) have tested interventions to reduce mental health consequences of contagious disease outbreaks. The primary objective of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together (SPIN-CHAT) Trial is to evaluate the effect of a videoconference-based program on symptoms of anxiety. Secondary objectives include evaluating effects on symptoms of depression, stress, loneliness, boredom, physical activity, and social interaction.

methodsThe SPIN-CHAT Trial is a pragmatic RCT that will be conducted using the SPIN-COVID-19 Cohort, a sub-cohort of the SPIN Cohort. Eligible participants will be SPIN-COVID-19 Cohort participants without a positive COVID-19 test, with at least mild anxiety (PROMIS Anxiety 4a v1.0 T-score ≥ 55), not working from home, and not receiving current counselling or psychotherapy. We will randomly assign 162 participants to intervention groups of 7 to 10 participants each or waitlist control. We will use a partially nested RCT design to reflect dependence between individuals in training groups but not in the waitlist control. The SPIN-CHAT Program includes activity engagement, education on strategies to support mental health, and mutual participant support. Intervention participants will receive the 4-week (3 sessions per week) SPIN-CHAT Program via videoconference. The primary outcome is PROMIS Anxiety 4a score immediately post-intervention. ETHICS AND DISSEMINATION: The SPIN-CHAT Trial will test whether a brief videoconference-based intervention will improve mental health outcomes among at-risk individuals during contagious disease outbreak.

Indexed as

AnxietyCoronavirus InfectionsHealth PromotionPneumonia, ViralScleroderma, SystemicCOVID-19HumansPandemicsPatient-Centered CarePragmatic Clinical Trials as TopicProgram EvaluationRandomized Controlled Trials as TopicResearch DesignRisk AssessmentSocial IsolationVideoconferencingAnxietyCoronavirusCOVID-19Mental healthRCTSclerodermaSystemic sclerosisTrial

Identifiers

PMID32521358
PMCPMC7224675
OpenAlexW3025484094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.